verified SJR 1,252 · Q1 • database Scopus / SJR & Web of Science indexed

Switzerland

workspace_premium Q1 — Geriatrics and Gerontology lock Subscription

Drugs and Aging

Drugs and Aging is a journal indexed in SJR in Geriatrics and Gerontology and Pharmacology (medical) with an H index of 114. It has a price of 2480 €. It has an SJR impact factor of 1,252 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,252.

Drugs and Aging focuses its scope in these topics and keywords: patients, review, osteoarthritis, elderly, older, systematic, management, nonselective, immunodeficiency, antiinflammatory, ...

ISSN: 1170-229X

Category: Geriatrics and Gerontology

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

1,252 Q1

H-index 114

Acceptance rate pie_chart

24% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

2.480 € Subscription

Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

1,252

H-index

114

Docs (year)

Docs 3y

252

Total refs

5323

Cites 3y

965

Citable 3y

246

Cites/Doc 2y

Ref/Doc

64.13

Immediate OA

2480 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Antibiotic Prescribing in Long-Term Care Facilities: A Meta-synthesis of Qualitative Research

Zoster Vaccine Live (Oka/Merck)

Current Drug Treatment of Hyperlipidemia in Older Adults

Costs of Eprosartan versus Diuretics for Treatment of Hypertension in a Geriatric Population

Correction to: Interventions to Reduce Adverse Drug Event-Related Outcomes in Older Adults: A Systematic Review and Meta-analysis

Concerns About the Use of New Oral Anticoagulants for Stroke Prevention in Elderly Patients with Atrial Fibrillation

Clinically Significant Drug Interactions with Antidepressants in the Elderly

Catheter-Related Urinary Tract Infection

Brimonidine

Association of Anticholinergic Drugs with Hospitalization and Mortality among Older Cardiovascular Patients

Assessment and Management of Pressure Ulcers in the Elderly

Antidiabetic Treatment Patterns in a Medicare Advantage Population in the United States

SHOW MORE ARTICLES

Antibiotic Use and Associated Factors in Patients with Dementia: A Systematic Review

A Medical Economic Fairy Tale

Anti-Tumour Necrosis Factor-?? Therapy for Rheumatoid and Other Inflammatory Arthropathies

Anorexia

Analysis by Age Group of Disease Outcomes in Patients with Psoriatic Arthritis: A Cross-Sectional Multicentre Study

Adherence to Depression Treatment in Older Adults

Acknowledgement

Acetylcholinesterase Inhibitors and Sleep Architecture in Patients with Alzheimer???s Disease

A Taxonomy and Economic Consequences of Nursing Home Falls

A Systematic Review of the Clinical and Cost-Effectiveness of Memantine in Patients with Moderately Severe to Severe Alzheimer???s Disease

A Randomised, Controlled Clinical Trial Evaluating Changes in Therapeutic Efficacy and Oxidative Parameters after Treatment with Propionyl L-Carnitine in Patients with Peripheral Arterial Disease Requiring Haemodialysis

FAQs

Drugs and Aging has an SJR of 1,252 (best quartile Q1) in the CountryOfPapers database.

Immediate OA APC is 2480 EUR. Non-OA / submission fee is 0 EUR.

The acceptance rate recorded for Drugs and Aging is 24%.

Drugs and Aging

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Drugs and Aging?

What is the APC / publication cost?

What is the acceptance rate?